Huinno

Huinno is a digital health company that develops AI-powered and cloud-connected wearable devices for cardiac health monitoring and activity tracking, providing electrocardiogram solutions integrated with artificial intelligence and electrodes for arrhythmia detection. The company's wearable ECG device attaches to the human body and continuously monitors cardiac activity, using AI algorithms to detect arrhythmias and other cardiac abnormalities in real time. The device integrates with cloud-based platforms that enable healthcare providers to remotely monitor patient cardiac health, receive alerts for clinical deterioration, and track activity data for comprehensive patient management. Huinno's technology supports value-based care models by enabling remote cardiac monitoring, early detection of arrhythmias, and proactive intervention for patients with cardiovascular conditions, reducing hospital readmissions and improving patient outcomes. The company's platform combines hardware sensors, AI-driven signal processing, and cloud infrastructure to deliver continuous, non-invasive cardiac monitoring suitable for both clinical and home-use settings. Founded in 2015 and headquartered in New York City, Huinno has raised $47.6M in Series C funding from investors including Yuhan Corporation, Aju IB Investment, Smile Gate Investment, Shinhan Venture Investment, Synergy Net, Shinhan Capital, Daily Partners, KTB Network, NH Investment and Securities, Meritz Securities, Signite Partners, Tech Incubator Program for Startup, FuturePlay, 500 Global, and Shinhan Future.